A peptidomimetic of NT-3 acts as a TrkC antagonist

Peptides

Volumn 30, Issue 10, 2009, Pages 1833-1839

  Brahimi, Fouad ^a   Malakhov, Andrey ^b   Lee, Hong Boon ^b   Pattarawarapan, Mookda ^b   Ivanisevic, Lubijca ^a   Burgess, Kevin ^b   Saragovi, H Uri ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b TEXAS A AND M UNIVERSITY   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antagonism; Neurotrophin; Receptor; Tyrosine kinase

Indexed keywords

NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR; POLYPEPTIDE;

ANIMAL CELL; ARTICLE; BETA TURN; BIOMIMETICS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; MOLECULAR BIOLOGY; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; CELL SURVIVAL; MICE; MOLECULAR MIMICRY; MOLECULAR STRUCTURE; NEUROTROPHIN 3; NIH 3T3 CELLS; PEPTIDES; RECEPTOR, IGF TYPE 1; RECEPTOR, TRKA; RECEPTOR, TRKC; SIGNAL TRANSDUCTION;

EID: 70349314320     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.07.015     Document Type: Article

References (23)

1. Barbacid M. The Trk family of neurotrophin receptors. J Neurobiol 25 (1994) 1386-1403
2. Beglova N., Maliartchouk S., Ekiel I., Zaccaro M.C., Saragovi H.U., and Gehring K. Design and solution structure of functional peptide mimetics of nerve growth factor. J Med Chem 43 (2000) 3530-3540
3. Chao M.V., and Bothwell M. Neurotrophins: to cleave or not to cleave. Neuron 33 (2002) 9-12
4. Hempstead B.L. The many faces of p75NTR. Curr Opin Neurobiol 12 (2002) 260-267
5. Ivanisevic L., Zheng W., Woo S.B., Neet K.E., and Saragovi H.U. TrkA receptor "hot spots" for binding of NT-3 as a heterologous ligand. J Biol Chem 282 (2007) 16754-16763
6. Kaplan D.R., and Miller F.D. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10 (2000) 381-391
7. Kaplan D.R., and Miller F.D. Signal transduction by the neurotrophin receptors. Curr Opin Cell Biol 9 (1997) 213-221
8. Lee H.B., Zaccaro M.C., Pattarawarapan M., Roy S., Saragovi H.U., and Burgess K. Syntheses and activities of new C10 beta-turn peptidomimetics. J Org Chem 69 (2004) 701-713
9. Lee N.Y., Hazlett T.L., and Koland J.G. Structure and dynamics of the epidermal growth factor receptor C-terminal phosphorylation domain. Protein Sci 15 (2006) 1142-1152
10. LeSauteur L., Cheung N.K.V., Lisbona R., and Saragovi H.U. Small molecule nerve growth factor analogs image receptors in vivo. Nat Biotechnol 14 (1996) 1120-1122
11. LeSauteur L., Wei L., Gibbs B., and Saragovi H.U. Small peptide mimics of nerve growth factor bind TrkA receptors and affect biological responses. J Biol Chem 270 (1995) 6564-6569
12. Mahadeo D., Kaplan D., Chao M., and Hempstead B. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J Biol Chem 269 (1994) 6884-6991
13. Maliartchouk S., Debeir T., Beglova N., Cuello A., Gehring K., and Saragovi H. Genuine monovalent ligands of TrkA nerve growth factor receptors reveal a novel pharmacological mechanism of action. J Biol Chem 275 (2000) 9946-9956
14. Maliartchouk S., Feng Y., Ivanisevic L., Debeir T., Cuello A.C., Burgess K., et al. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Mol Pharmacol 57 (2000) 385-391
15. Maliartchouk S., and Saragovi H.U. Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands. J Neurosci 17 (1997) 6031-6037
16. McInnes C., and Sykes B.D. Growth factor receptors: structure, mechanism, and drug discovery. Biopolymers 43 (1997) 339-366
17. Pautsch A., Zoephel A., Ahorn H., Spevak W., Hauptmann R., and Nar H. Crystal structure of bisphosphorylated IGF-1 receptor kinase: insight into domain movements upon kinase activation. Structure 9 (2001) 955-965
18. Saragovi H.U., and Burgess K. Small molecule and protein-based neurotrophic ligands: agonists and antagonists as therapeutic agents. Exp Opin Ther Patents 9 (1999) 737-751
19. Saragovi H.U., and Gehring K. Development of pharmacological agents for targeting neurotrophins and their receptors. Trends Pharmacol Sci 21 (2000) 93-98
20. Saragovi H.U., and Zaccaro M.C. Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites. Curr Pharm Des 8 (2002) 2201-2216
21. Stein R.A., Hustedt E.J., Staros J.V., and Beth A.H. Rotational dynamics of the epidermal growth factor receptor. Biochemistry 41 (2002) 1957-1964
22. Zaccaro M.C., Ivanisevic L., Perez P., Meakin S.O., and Saragovi H.U. p75 Co-receptors regulate ligand-dependent and ligand-independent Trk receptor activation, in part by altering Trk docking subdomains. J Biol Chem 276 (2001) 31023-31029
23. Zaccaro M.C., Lee H.B., Pattarawarapan M., Xia Z., Caron A., L'Heureux P.J., et al. Selective small molecule peptidomimetic ligands of TrkC and TrkA receptors afford discrete or complete neurotrophic activities. Chem Biol 12 (2005) 1015-1028